Differential crizotinib efficacy among ROS1 fusion partners in ROS1-positive non-small cell lung cancer.

被引:1
作者
Lu, Shun
Li, Ziming
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Clin Med Ctr, Shanghai, Peoples R China
关键词
D O I
10.1200/JCO.2017.35.15_suppl.9067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9067
引用
收藏
页数:5
相关论文
empty
未找到相关数据